Hypolipidemic alkenesulfonamides
AssigneePfizer Inc.
InventorGerald F. Holland
Life of this patent
Estimating the term…
Abstract
Method for lowering blood lipid levels in mammals, using certain derivatives of N-carbamoyl-2-phenylethenesulfonamide, many of which are novel.
Claims7
A method for lowering elevated blood lipid levels in a hyperlipidemic mammal which comprises administering to said mammal a blood lipid level lowering amount of a compound selected from the group consisting of ##STR13## and the pharmaceutically acceptable salts thereof wherein X is selected from the group consisting of hydrogen, chloro and methyl;
- A and B are each selected from the group consisting of hydrogen, methyl and ethyl and Z is 1,2,3,4-tetrahydroisoquinolino.
A compound selected from the group consisting of ##STR14## and the pharmaceutically acceptable salts thereof wherein X is selected from the group consisting of hydrogen, chloro and methyl;
- A and B are each selected from the group consisting of hydrogen, methyl and ethyl and Z is 1,2,3,4-tetrahydroisoquinolino.
Dependencies are inferred from the claim text.